Drebrin Activators
The class of compounds known as Drebrin Activators comprises a diverse range of chemicals that exhibit the ability to modulate Drebrin expression and function through distinct cellular pathways. Lithium compounds, including lithium chloride and lithium carbonate, are noteworthy members of this class, acting as indirect activators by inhibiting GSK-3β and subsequently activating the Wnt/β-catenin pathway, resulting in enhanced Drebrin levels. Forskolin, a potent activator of adenylate cyclase, influences Drebrin indirectly by upregulating cAMP levels and activating the cAMP-PKA-CREB pathway. Similarly, compounds like resveratrol and curcumin demonstrate indirect activation by affecting the SIRT1 and NF-κB pathways, respectively, leading to enhanced Drebrin expression. Quercetin, through its influence on the AMPK-mTOR axis, provides another avenue for Drebrin activation.
Compounds such as sodium valproate, sulforaphane, and thymoquinone contribute to Drebrin activation by modulating pathways like GSK-3β, Nrf2, and ERK, respectively. Sodium butyrate, as an inhibitor of HDACs, influences Drebrin expression through the epigenetic regulation of gene expression. Additionally, 6-benzylaminopurine and glycerol trinitrate exert their effects by impacting the MAPK and cGMP-PKG pathways, respectively, indirectly activating Drebrin. The intricate network of signaling pathways influenced by Drebrin Activators highlights the multifaceted nature of these compounds. Understanding their specific biochemical interactions and cellular mechanisms provides valuable insights for manipulating Drebrin levels in diverse cellular contexts, laying the foundation for applications in research and cellular modulation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, leading to increased cAMP levels. Elevated cAMP activates PKA, which phosphorylates and activates CREB. Drebrin is a downstream target of CREB, and its expression is enhanced upon CREB activation. Therefore, Forskolin indirectly activates Drebrin by modulating the cAMP-PKA-CREB pathway. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol activates the SIRT1 pathway, which influences various cellular processes. SIRT1 deacetylates and activates FOXO3a, a transcription factor that positively regulates Drebrin expression. Through the SIRT1-FOXO3a axis, resveratrol indirectly activates Drebrin expression, providing a potential avenue for modulating Drebrin levels in cellular contexts. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride influences the Wnt/β-catenin signaling pathway by inhibiting GSK-3β, a downstream regulator. This disruption leads to the activation of Drebrin, as GSK-3β is known to negatively regulate Drebrin expression. The inhibition of GSK-3β by lithium chloride results in enhanced Drebrin expression and function. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin influences the NF-κB signaling pathway by inhibiting IKKβ, a key regulator of NF-κB activation. The downstream effect includes the upregulation of Drebrin expression, as NF-κB can modulate the transcription of Drebrin. Curcumin's impact on the NF-κB pathway indirectly activates Drebrin, providing a potential avenue for controlling Drebrin levels in cellular contexts. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $110.00 $250.00 $936.00 $50.00 | 33 | |
Quercetin is known to activate AMPK, a cellular energy sensor. AMPK activation leads to the inhibition of mTOR, a regulator of protein synthesis. Drebrin, being a downstream target of mTOR, is influenced by quercetin through the AMPK-mTOR axis. This indirect modulation results in the activation of Drebrin expression and function, offering a potential mechanism for controlling Drebrin levels. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
Sodium valproate influences the GSK-3β pathway, similar to lithium compounds. By inhibiting GSK-3β, it activates the Wnt/β-catenin pathway, leading to enhanced Drebrin expression. Sodium valproate's impact on GSK-3β provides a potential avenue for indirectly activating Drebrin expression and function, making it a candidate for modulating Drebrin levels in cellular contexts. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $153.00 $292.00 $489.00 $1325.00 $8465.00 $933.00 | 22 | |
Sulforaphane activates the Nrf2 pathway, a key regulator of cellular antioxidant responses. Nrf2 activation leads to the upregulation of Drebrin expression, as Drebrin has been identified as a target gene of Nrf2. Therefore, sulforaphane indirectly activates Drebrin by modulating the Nrf2 pathway, providing a potential mechanism for controlling Drebrin levels in cellular contexts. | ||||||
Thymoquinone | 490-91-5 | sc-215986 sc-215986A | 1 g 5 g | $47.00 $133.00 | 21 | |
Thymoquinone activates the ERK signaling pathway, which is involved in cell proliferation and survival. ERK activation positively influences Drebrin expression, making thymoquinone an indirect activator of Drebrin through the modulation of the ERK pathway. The activation of Drebrin by thymoquinone offers a potential avenue for controlling Drebrin levels in cellular contexts by targeting the ERK signaling cascade. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate influences the HDAC pathway by inhibiting histone deacetylases. This inhibition leads to the hyperacetylation of histones, affecting gene expression. Drebrin, being a downstream target of HDACs, is influenced by sodium butyrate through the HDAC pathway. The upregulation of Drebrin expression provides a potential mechanism for indirectly activating Drebrin in cellular contexts. | ||||||
6-Benzylaminopurine | 1214-39-7 | sc-202428 sc-202428A | 1 g 5 g | $20.00 $52.00 | ||
6-Benzylaminopurine is a synthetic cytokinin that influences the MAPK pathway by activating the expression of genes involved in cell differentiation and growth. Drebrin expression is influenced by the MAPK pathway, making 6-benzylaminopurine an indirect activator of Drebrin. The activation of Drebrin by this compound provides a potential avenue for modulating Drebrin levels in cellular contexts through MAPK pathway modulation. | ||||||